Mellott, T. J., Pender, S. M., Burke, R. M., Langley, E. A., & Blusztajn, J. K. (2014). IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice. Public Library of Science.
Citação norma ChicagoMellott, Tiffany J., Sarah M. Pender, Rebecca M. Burke, Erika A. Langley, and Jan Krzysztof Blusztajn. IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice. Public Library of Science, 2014.
Citação norma MLAMellott, Tiffany J., et al. IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice. Public Library of Science, 2014.